Cetuximab versus cisplatin in patients with HPV-positive, low risk oropharyngeal cancer, receiving radical radiotherapy

H. Mehanna; A. Kong; A. Hartley; P. Mistry; M. Dalby; T. Fulton-Lieuw; M. Robinson; A. Gray; B. Foran; M. Sen; L. O'Toole; K. Dyker; H. Al Booz; R. Moleron; S. Brennan; E. Aynsley; A. Chan; D. Srinivasan; J. Buter; J. Dunn

doi:https://doi.org/10.1093/annonc/mdy424.046

Cetuximab versus cisplatin in patients with HPV-positive, low risk oropharyngeal cancer, receiving radical radiotherapy

H. Mehanna, A. Kong, A. Hartley, P. Mistry, M. Dalby, T. Fulton-Lieuw, M. Robinson, A. Gray, B. Foran, M. Sen, L. O'Toole, K. Dyker, H. Al Booz, R. Moleron, S. Brennan, E. Aynsley, A. Chan, D. Srinivasan, J. Buter, J. Dunn

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	viii729-viii730
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy424.046
Publication status	Published - 1 Oct 2018

Access to Document

https://doi.org/10.1093/annonc/mdy424.046

Cite this

Mehanna, H., Kong, A., Hartley, A., Mistry, P., Dalby, M., Fulton-Lieuw, T., Robinson, M., Gray, A., Foran, B., Sen, M., O'Toole, L., Dyker, K., Al Booz, H., Moleron, R., Brennan, S., Aynsley, E., Chan, A., Srinivasan, D., Buter, J., & Dunn, J. (2018). Cetuximab versus cisplatin in patients with HPV-positive, low risk oropharyngeal cancer, receiving radical radiotherapy. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii729-viii730. https://doi.org/10.1093/annonc/mdy424.046

@article{87b7098b77e74d56b8384503833b53da,

title = "Cetuximab versus cisplatin in patients with HPV-positive, low risk oropharyngeal cancer, receiving radical radiotherapy",

author = "H. Mehanna and A. Kong and A. Hartley and P. Mistry and M. Dalby and T. Fulton-Lieuw and M. Robinson and A. Gray and B. Foran and M. Sen and L. O'Toole and K. Dyker and {Al Booz}, H. and R. Moleron and S. Brennan and E. Aynsley and A. Chan and D. Srinivasan and J. Buter and J. Dunn",

year = "2018",

month = oct,

day = "1",

doi = "https://doi.org/10.1093/annonc/mdy424.046",

language = "English",

volume = "29",

pages = "viii729--viii730",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

Mehanna, H, Kong, A, Hartley, A, Mistry, P, Dalby, M, Fulton-Lieuw, T, Robinson, M, Gray, A, Foran, B, Sen, M, O'Toole, L, Dyker, K, Al Booz, H, Moleron, R, Brennan, S, Aynsley, E, Chan, A, Srinivasan, D, Buter, J & Dunn, J 2018, 'Cetuximab versus cisplatin in patients with HPV-positive, low risk oropharyngeal cancer, receiving radical radiotherapy', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii729-viii730. https://doi.org/10.1093/annonc/mdy424.046

Cetuximab versus cisplatin in patients with HPV-positive, low risk oropharyngeal cancer, receiving radical radiotherapy. / Mehanna, H.; Kong, A.; Hartley, A. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii729-viii730.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Cetuximab versus cisplatin in patients with HPV-positive, low risk oropharyngeal cancer, receiving radical radiotherapy

AU - Mehanna, H.

AU - Kong, A.

AU - Hartley, A.

AU - Mistry, P.

AU - Dalby, M.

AU - Fulton-Lieuw, T.

AU - Robinson, M.

AU - Gray, A.

AU - Foran, B.

AU - Sen, M.

AU - O'Toole, L.

AU - Dyker, K.

AU - Al Booz, H.

AU - Moleron, R.

AU - Brennan, S.

AU - Aynsley, E.

AU - Chan, A.

AU - Srinivasan, D.

AU - Buter, J.

AU - Dunn, J.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85081529081&partnerID=8YFLogxK

U2 - https://doi.org/10.1093/annonc/mdy424.046

DO - https://doi.org/10.1093/annonc/mdy424.046

M3 - Article

C2 - 32138008

SN - 0923-7534

VL - 29

SP - viii729-viii730

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

Cetuximab versus cisplatin in patients with HPV-positive, low risk oropharyngeal cancer, receiving radical radiotherapy

Access to Document

Other files and links

Cite this